Viewing data from:

RALOXIFENE HYDROCHLORIDE

ANDA

RALOXIFENE HYDROCHLORIDE | A211324 | CADILA PHARMACEUTICALS LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: EVISTA(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.2399

per ea

Lowest NADAC/Unit

$0.2399

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
72241001005RALOXIFENE HCL 60 MG TABLET	$0.2399	EA	Generic	—	2026-06-17
72241001011RALOXIFENE HCL 60 MG TABLET	$0.2399	EA	Generic	—	2026-06-17
72241001022RALOXIFENE HCL 60 MG TABLET	$0.2399	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain14 active DMFs6 inactive

14 active API suppliers hold Drug Master Files for this ingredient.

ERREGIERRE SPARALOXIFENE HYDROCHLORIDE

DMF 159322002

DR REDDYS LABORATORIES LTDRALOXIFENE HYDROCHLORIDE USP

DMF 161432002

AARTI DRUGS LTDRALOXIFENE HYDROCHLORIDE USP

DMF 216502008

GLOCHEM INDUSTRIES PRIVATE LTDRALOXIFENE HYDROCHLORIDE

DMF 216822008

CAMBREX PROFARMACO MILANO SRLRALOXIFENE HYDROCHLORIDE

DMF 229272009

HETERO DRUGS LTDRALOXIFENE HYDROCHLORIDE USP

DMF 252812011

APITORIA PHARMA PRIVATE LTDRALOXIFENE HYDROCHLORIDE USP (NON-STERILE DRUG SUBSTANCE)

DMF 256502012

CADILA PHARMACEUTICALS LTDRALOXIFENE HYDROCHLORIDE USP

DMF 270642013

TAPI NL BVRALOXIFENE HYDROCHLORIDE

DMF 279692014

OLON SPARALOXIFENE HYDROCHLORIDE

DMF 297212015

RAKS PHARMA PVT LTDRALOXIFENE HYDROCHLORIDE, USP

DMF 319522017

AURORE LIFE SCIENCES PRIVATE LTDRALOXIFENE HYDROCHLORIDE USP

DMF 364452021

MEDILUX LABORATORIES PVT LTDRALOXIFENE HYDROCHLORIDE USP

DMF 391752023

ALIVUS LIFE SCIENCES LTDRALOXIFENE HYDROCHLORIDE USP

DMF 416112025

EXCELLA GMBHInactiveRALOXIFENE HYDROCHLORIDE

DMF 174152004

CIPLA LTDInactiveRALOXIFENE HYDROCHLORIDE

DMF 201632007

TEVA PHARMACEUTICALS INDUSTRIES LTDInactiveRALOXIFENE HYDROCHLORIDE BULK DRUG SUBSTANCE

DMF 213272008

APOTEX PHARMACHEM INDIA PVT LTDInactiveRALOXIFENE HYDROCHLORIDE USP

DMF 245892011

SICHUAN XIELI PHARMACEUTICAL CO LTDInactiveRALOXIFENE HYDROCHLORIDE

DMF 264922012

CIPLA LTDInactiveRALOXIFENE HYDROCHLORIDE USP

DMF 328982018

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 60MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Aug 18, 2020

No patent or exclusivity listings for this strength.